Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma
Authors:
- W. LumryWLW. Lumry
- R. NoveckRNR. Noveck
- S. WeinsteinSWS. Weinstein
- F. BarnhartFBF. Barnhart
- A. VandermeerAVA. Vandermeer
- A. MurrayAMA. Murray
- C. ReisnerCRC. Reisner
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (3) , 297-303
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A United States regulator’s perspective on the ongoing chlorofluorocarbon transitionJournal of Allergy and Clinical Immunology, 1999
- Cumulative Dose Response Study Comparing HFA-134a Albuterol Sulfate and Conventional CFC Albuterol in Patients with AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Proventil HFA Provides Protection from Exercise-Induced Bronchoconstriction Comparable to Proventil and VentolinAnnals of Allergy, Asthma & Immunology, 1997
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Compliance and Outcomes in Patients with AsthmaDrugs, 1996
- CFCs, their Replacements, and the Ozone LayerJournal of Aerosol Medicine, 1995
- The Montreal Protocol and Essential Use ExemptionsJournal of Aerosol Medicine, 1995
- AsthmaNew England Journal of Medicine, 1992
- The CFC-Ozone Issue: Progress on the Development of Alternatives to CFCsScience, 1990
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985